Takahiro Kamiya

7PUBLICATIONS
42CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 28, 2025
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome.

Motohiko Oshima, Naoya Takayama, Yaeko Nakajima-Takagi

|Sep 02, 2025
Identification of a CD138-Negative Therapy-Resistant Subpopulation in Multiple Myeloma with Vulnerability to Splicing Factor Inhibition.

Takahiro Kamiya, Masahiko Ajiro, Motohiko Oshima

|Mar 25, 2025
Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span.

Shuhei Koide, Motohiko Oshima, Takahiro Kamiya

|Nov 18, 2021
Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma.

Takahiro Kamiya, Masatoshi Sakurai, Taku Kikuchi

|Apr 21, 2020
The prognostic value of the controlling nutritional status score in patients with multiple myeloma.

Takahiro Kamiya, Chisako Ito, Yuriko Fujita

Pageof 2

Frequent Collaborators

3 joint publications

Atsushi Iwama

2 joint publications

Yuriko Nishiyama-Fujita

2 joint publications

Noriko Doki

2 joint publications

Atsushi Kaneda